Why Your Cardiac Surgeon Calculated a EuroSCORE II — and Why You Should Understand It
If you are facing heart surgery — whether it is coronary artery bypass grafting, a valve replacement, or a combined procedure — your surgical team is almost certainly running your clinical data through a risk calculator. In many hospitals around the world, that calculator is EuroSCORE II.
As a board-certified cardiovascular and thoracic surgeon, I use risk scores every day. They are not crystal balls. They do not predict exactly what will happen to you on the operating table. But they are among the best tools we have to frame the conversation about what surgery means for you specifically — not for a hypothetical average patient, but for someone with your age, your kidney function, your heart muscle strength, and your particular combination of medical problems.
The problem is that most patients never hear these numbers explained in plain language. You might be told your risk is "acceptable" or "elevated" without understanding the framework behind that judgment. This article is my attempt to change that. I want you to understand what the EuroSCORE II calculator measures, where it is strong, where it falls short, and how it fits alongside other risk tools like the STS risk score that we also discuss on this blog.
What the EuroSCORE II Calculator Actually Measures
EuroSCORE stands for the European System for Cardiac Operative Risk Evaluation. The original version — sometimes called EuroSCORE I or the logistic EuroSCORE — was developed in the late 1990s using data from nearly 20,000 patients across 128 hospitals in eight European countries. It was a landmark achievement: for the first time, surgeons had a validated, widely adopted model that could estimate the probability of in-hospital mortality after cardiac surgery.
By the late 2000s, however, the original model was clearly showing its age. Surgical techniques had improved, perioperative care was better, and the original EuroSCORE was consistently overestimating risk — sometimes dramatically. A patient calculated to have a 20% mortality risk might actually face something closer to 5%. That kind of overestimation is not harmless. It can steer patients away from beneficial operations or, conversely, make results look artificially good.
EuroSCORE II was introduced in 2012. It was built from a newer dataset of over 22,000 patients from 154 hospitals in 43 countries. The model was recalibrated to reflect modern surgical practice. It includes 18 variables grouped into three broad categories:
- Patient-related factors: Age, sex, chronic lung disease, poor mobility, previous cardiac surgery, diabetes on insulin, renal function (measured by creatinine clearance), and active endocarditis
- Cardiac-related factors: NYHA class (a measure of heart failure symptoms), angina class, left ventricular function, recent heart attack, and pulmonary artery pressure
- Operation-related factors: Urgency of surgery, type of procedure (isolated CABG, single valve, multiple procedures), whether thoracic aorta surgery is involved, and whether there is a ventricular septal rupture
The calculator processes these inputs through a logistic regression model and outputs a percentage — your estimated risk of dying during or shortly after the operation. For a low-risk isolated CABG, that number might be well under 1%. For a complex redo operation in a patient with kidney failure and depressed heart function, it could be 10%, 20%, or higher.
If you want to see how risk calculators work with your own clinical data, our free cardiac surgery risk calculator can walk you through the process and help you prepare better questions for your surgical team.
EuroSCORE vs STS: Understanding the Two Major Risk Scores
One of the most common questions I receive from patients — especially those doing their own research — is about the difference between EuroSCORE and the STS (Society of Thoracic Surgeons) risk score. This is a genuinely important question, and the answer matters for how you interpret the numbers you are given.
Here are the key differences:
Geographic origin and dataset
EuroSCORE II was developed primarily from European surgical data, though the 2012 update incorporated centers from 43 countries. The STS risk model is built almost entirely from North American data — specifically, the STS Adult Cardiac Surgery Database, which now includes data from more than 7 million procedures across the United States and Canada. If you are having surgery in North America, the STS score is generally considered more representative of local practice patterns and outcomes.
What they predict
EuroSCORE II predicts in-hospital mortality — the chance of dying before you leave the hospital. The STS score predicts operative mortality (death within 30 days or during the same hospitalization) plus several major complications: stroke, renal failure, prolonged ventilation, deep sternal wound infection, and reoperation. This broader scope makes the STS score particularly useful for counseling patients about what recovery might look like, not just whether they will survive.
Procedure-specific calibration
The STS has developed separate, highly specific models for isolated CABG, isolated aortic valve replacement, isolated mitral valve surgery, and various combinations. EuroSCORE II uses a single model for all cardiac surgery types, adjusting with procedure-type variables. In practice, this means the STS models tend to be better calibrated for specific operations, while EuroSCORE II offers broader applicability — including for procedures the STS does not have a dedicated model for.
Where each score is preferred
In the United States, the STS score dominates clinical practice and is the standard used by CMS (Medicare) for quality reporting. In Europe, the United Kingdom, the Middle East, and much of Asia, the European cardiac surgery risk score remains the default. Many major centers calculate both and compare. When I evaluate a complex case, I often want to see both numbers side by side. If EuroSCORE II and STS give me significantly different estimates, that discrepancy itself is informative and warrants closer analysis.
According to a 2014 comparative study published in the European Journal of Cardio-Thoracic Surgery, both EuroSCORE II and STS demonstrated reasonable discrimination (the ability to rank patients by risk), but calibration — how closely predicted risk matches actual observed risk — varied depending on the patient population and procedure type. Neither score is universally superior. Each has blind spots.
Where EuroSCORE II Falls Short — and What That Means for You
No risk calculator is perfect. I tell my patients this directly because I believe understanding the limitations of a tool is just as important as understanding its output. Here is where the EuroSCORE II calculator has known weaknesses:
- Frailty is underrepresented. EuroSCORE II includes a "poor mobility" variable, but frailty is a complex syndrome involving nutrition, muscle mass, cognitive reserve, and physiologic resilience. A patient who is technically mobile but profoundly frail may have a much higher real-world risk than EuroSCORE II predicts. The STS score has similar limitations in this area.
- It may underestimate risk in very high-risk patients. Some studies — including a 2018 analysis in Interactive Cardiovascular and Thoracic Surgery — have found that while EuroSCORE II corrected the overestimation problem of the original model, it now occasionally underestimates risk at the high end of the spectrum, particularly in patients undergoing combined procedures or those with severely impaired ventricular function.
- It does not account for surgeon or institutional quality. A EuroSCORE II of 4% at a high-volume center with dedicated cardiac intensive care may represent a very different real risk than the same score at a low-volume hospital. Risk scores model patient complexity; they do not model the skill of the team caring for you.
- Liver disease, porcelain aorta, and other clinical nuances are absent. There are factors experienced surgeons weigh heavily — severe hepatic dysfunction, a heavily calcified ascending aorta, hostile chest from prior radiation — that simply are not captured in the EuroSCORE II model.
This is precisely why a risk score should start a conversation, not end one. If your surgeon tells you your EuroSCORE II is 8% and recommends proceeding, you should feel entitled to ask: What factors does that number not capture? Based on your experience, do you think my actual risk is higher or lower than that estimate?
How to Use Your European Cardiac Surgery Risk Score in Decision-Making
Here is my practical advice for patients who have been given a risk score — whether it is EuroSCORE II, STS, or both:
1. Ask for the actual number. Do not accept vague reassurances like "your risk is low" or "this is a routine case." You have a right to know the predicted mortality and major complication rates. Write them down.
2. Understand what the number means — and what it does not. A predicted mortality of 3% means that in a group of 100 patients with a similar clinical profile, roughly 3 would be expected to die. It does not mean you personally have a 3% chance of dying. Your actual risk is influenced by dozens of factors these models cannot measure.
3. Ask how the number influenced the recommendation. In some cases, a high EuroSCORE II might lead a surgeon to recommend a less invasive approach — for example, TAVR instead of surgical aortic valve replacement in a patient with severe aortic stenosis. In other cases, it might support a decision to pursue aggressive surgery because the risk of not operating is even higher. The score is a tool for decision-making, not the decision itself.
4. Compare it with a second perspective. Risk scores are interpreted in context, and context varies between surgeons and institutions. A cardiac surgery second opinion gives you another experienced set of eyes reviewing your imaging, your cath report, your labs, and your risk profile. In my practice, I have seen cases where the surgical plan changed after a thorough independent review — not because the first surgeon was wrong, but because there were reasonable alternatives that had not been fully explored.
5. Factor in your own values and priorities. A 5% mortality risk means something different to a 55-year-old with young children than to an 85-year-old who has expressed a strong preference for comfort over intervention. Risk scores inform decisions. They do not make them for you.
When a Second Look at Your Risk Assessment Makes the Difference
I founded WhiteGloveMD because I saw too many patients making life-altering surgical decisions without the full picture. Sometimes that means they were not told about a less invasive option. Sometimes it means a risk score was calculated but never explained. And sometimes it means the score itself was based on incomplete data — a missing echocardiographic measurement, an outdated creatinine value, or a procedure code that did not accurately reflect what was actually being planned.
A thorough second opinion review includes recalculating your risk with current, verified data; comparing EuroSCORE II and STS results where appropriate; evaluating whether the proposed operation is the right one for your anatomy and your goals; and ensuring you understand the numbers that are driving the recommendation.
If you are facing cardiac surgery and you have been given a risk score that worries you — or one that was never clearly explained — a WhiteGloveMD second opinion can help you understand your true risk profile and make sure the surgical plan is right for you. Start your review here, and get the clarity you deserve before making this decision.